News

The global companion diagnostics market is set to surge from USD 7.03 Billion in 2024 to USD 22.83 Billion by 2034, driven by rising cancer prevalenc ...
Using both liquid and tissue biopsies to guide targeted treatment may improve outcomes in patients with solid tumor malignancies.